Loncar China BioPharma ETF
ALTAR
Score™
3.7% info Recommen-
dation
AVOID
2020E    2021E
P/E
ratio
28.3x P/Sales
ratio
0.9x
P/BV
ratio
2.2x Div.
yield
1.4%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
The Loncar China BioPharma ETF tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry.

FUND BASICS
Category Emerging Market Equities
Fund Sponsor Exchange Traded Concepts
Website loncarfunds.com
Inception date Aug 14, 2018
Assets (mns) $10
Currency USD
Expense ratio 79 bp
Distributions Annually

FUND STRUCTURE
Regulation Open-Ended Fund
Custodian
Weighting Tiered
Index replication
Uses derivatives No
Options available No

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 37
Wgt avg mkt cap (mns) $4,285
Large cap (>$10bn) 25.2%
Mid cap ($2-10bn) 53.9%
Small cap (<$2bn) 20.9%
Developed mkts 55.6%
Emerging mkts 44.4%

TOP TEN HOLDINGS
WUXI BIOLOGICS (CAYMAN) INC. 4.2 %
WUXI APPTEC CO., LTD. CLASS H 4.0 %
SINO BIOPHARMACEUTICAL 3.9 %
BEIGENE LTD. SPONSORED ADR 3.6 %
ZAI LAB LTD. UNSPONSORED ADR 3.6 %
CHINA PHARMACEUTICAL GROUP 2.8 %
SHANGHAI FOSUN PHARMACEUTI-H 2.7 %
LIVZON PHARMACEUTICAL GROU-H 2.7 %
SINOPHARM GROUP CO-H 2.7 %
CHINA BIOLOGIC PRODUCTS HOLDINGS, 2.4 %
Total 32.7 %

TOP COUNTRY EXPOSURE
CHINA 44.0 %
HONG KONG 11.9 %
UNITED STATES 3.2 %








HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru May 31)
Year-to-date 1 year 5 years 10 years Since Incep.
8.2% 23.7% -- -- 9.5%

Market Correlations
versus... Beta R-squared
S&P500 0.93 51%
MSCI EAFE 0.93 42%
MSCI Emg. Mkts. 0.83 48%

Technical Indicators
Recent close $27.77
30d moving avg. $26.23
Annualized volatility 28.4%
Short interest (ETF) 0.0%
Relative strength (RSI) 59

Liquidity measures
Avg. volume (thou.) 7
Turnover 1.9%
Bid/Ask (% of price) 0.93%
ADV underlying (mns) $358

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 100 potential alternatives to the Loncar China BioPharma ETF ETF based on the alternatives' overlap in portfolio holdings with CHNA. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: CHNA Expense: 79 bp ALTAR Score™: 3.7%


ALTERNATIVE ETFs BASED ON OVERLAP WITH CHNA
Ticker Fund
Name
Overlap1
vs CHNA
(%)
Expense
ratio
(bp)
Savings
vs CHNA
(bp)
ALTAR
Score™
(%)
ALTAR
vs CHNA
(%)
CHIH Global X MSCI China Health Care ETF 32.5 65 14 3.9 +0.2
KURE KraneShares MSCI All China Health Care Index ETF 20.6 65 14 3.3 -0.4
KMED KraneShares Emerging Markets Healthcare Index ETF 4.6 79 0 2.4 -1.2
EEMD AAM S&P Emerging Markets High Dividend Value ETF 4.5 50 29 20.8 +17.2
HELX Franklin Genomic Advancements ETF 4.2 50 29 -1.8 -5.5
EMGF iShares Edge MSCI Multifactor Emerging Markets ETF 4.2 45 34 10.0 +6.3
ZHOK SPDR Solactive Hong Kong ETF 4.2 14 65 7.6 +4.0
GDNA Goldman Sachs Motif Human Evolution ETF 4.1 50 29 0.3 -3.4
FPXI First Trust International Equity Opportunities ETF 4.0 70 9 2.8 -0.9
PGJ Invesco Golden Dragon China ETF 3.9 70 9 3.4 -0.3
FHK First Trust Hong Kong AlphaDEX Fund 3.9 80 -1 10.5 +6.9
CXSE WisdomTree China ex-State-Owned Enterprises Fund 3.6 32 47 7.0 +3.3
CNCR Loncar Cancer Immunotherapy ETF 3.2 79 0 -3.4 -7.1
MOTI VanEck Vectors Morningstar International Moat ETF 3.0 57 22 8.3 +4.6
FDEM Fidelity Targeted Emerging Markets Factor ETF 2.9 45 34 9.7 +6.1
CHIL Global X MSCI China Large-Cap 50 ETF 2.9 29 50 9.5 +5.9
EMDV ProShares MSCI Emerging Markets Dividend Growers ETF 2.6 60 19 8.4 +4.8
FNI First Trust Chindia ETF 2.6 59 20 3.4 -0.2
MCHI iShares MSCI China ETF 2.6 59 20 9.1 +5.4
FLCH Franklin FTSE China ETF 2.5 19 60 9.2 +5.6
FCA First Trust China AlphaDEX Fund 2.5 80 -1 15.0 +11.3
GXC SPDR S&P China ETF 2.4 59 20 8.9 +5.3
KALL KraneShares FTSE Emerging Markets Plus ETF 2.3 49 30 9.2 +5.5
GNOM Global X Genomics & Biotechnology ETF 2.3 68 11 -3.6 -7.2
EDOG ALPS Emerging Sector Dividend Dogs ETF 2.2 60 19 10.4 +6.8
BICK First Trust BICK Index Fund 2.1 64 15 4.4 +0.7
EEMO Invesco S&P Emerging Markets Momentum ETF 2.0 30 49 7.1 +3.5
ESGE iShares ESG MSCI EM ETF 1.9 25 54 9.7 +6.0
FPA First Trust Asia Pacific ex-Japan AlphaDEX Fund 1.8 80 -1 8.1 +4.5
MXDE Nationwide Maximum Diversification Emerging Mkts Core Eq 1.8 64 15 5.3 +1.7
UEVM VictoryShares USAA MSCI Emerging Markets Value Momentum ETF 1.8 45 34 13.5 +9.8
ROAM Hartford Multifactor Emerging Markets ETF 1.8 44 35 14.8 +11.2
BKF iShares MSCI BRIC ETF 1.8 69 10 8.5 +4.8
IBB iShares NASDAQ Biotechnology ETF 1.8 47 32 0.4 -3.3
DGRE WisdomTree Emerging Markets Quality Dividend Growth Fund 1.7 32 47 9.5 +5.9
BBH VanEck Vectors Biotech ETF 1.7 35 44 3.7 +0.1
CN Xtrackers MSCI All China Equity ETF 1.7 50 29 9.4 +5.7
DVEM WisdomTree Emerging Markets Dividend Fund 1.6 32 47 9.1 +5.4
EMSG Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF 1.6 20 59 7.6 +4.0
WCHN WisdomTree ICBCCS S&P China 500 Fund 1.6 55 24 9.2 +5.5
QLVE FlexShares Emerging Markets Quality Low Volatility Index Fun 1.5 40 39 7.9 +4.2
EWH iShares MSCI Hong Kong ETF 1.5 49 30 7.7 +4.0
ECNS iShares MSCI China Small-Cap ETF 1.5 59 20 11.9 +8.3
EELV Invesco S&P Emerging Markets Low Volatility ETF 1.4 29 50 9.9 +6.3
NUEM Nuveen ESG Emerging Markets Equity ETF 1.4 45 34 7.8 +4.2
EMCG WisdomTree Emerging Markets Consumer Growth Fund 1.4 32 47 7.9 +4.3
LNGR Global X Longevity Thematic ETF 1.3 50 29 3.0 -0.6
GMF SPDR S&P Emerging Asia Pacific ETF 1.3 49 30 8.0 +4.3
EEMA iShares MSCI Emerging Markets Asia ETF 1.3 50 29 8.4 +4.8
IPOS Renaissance International IPO ETF 1.2 80 -1 5.0 +1.4
AAXJ iShares MSCI All Country Asia ex Japan ETF 1.2 68 11 8.0 +4.3
XSOE WisdomTree Emerging Markets ex-State-Owned Enterprises Fund 1.2 32 47 6.8 +3.1
LVIN Hartford Multifactor Low Volatility International Equity ETF 1.1 29 50 12.2 +8.5
RFEM First Trust Riverfront Dynamic Emerging Markets ETF 1.1 95 -16 10.1 +6.5
XT iShares Exponential Technologies ETF 1.1 47 32 5.2 +1.5
SCHE Schwab Emerging Markets Equity ETF 1.1 13 66 8.7 +5.0
EMMF WisdomTree Emerging Markets Multifactor Fund 1.1 48 31 9.9 +6.2
FLAX Franklin FTSE Asia Ex Japan ETF 1.1 19 60 8.5 +4.8
PBEE Invesco PureBeta FTSE Emerging Markets ETF 1.0 14 65 9.5 +5.9
CEZ VictoryShares Emerging Market Volatility Wtd Index ETF 1.0 50 29 9.9 +6.2
VWO Vanguard FTSE Emerging Markets ETF 1.0 10 69 8.8 +5.2
EEMX SPDR MSCI Emerging Markets Fossil Fuel Free ETF 1.0 30 49 8.8 +5.1
PIE Invesco DWA Emerging Markets Momentum ETF 1.0 90 -11 5.7 +2.1
DBEM Xtrackers MSCI Emerging Markets Hedged Equity ETF 1.0 65 14 8.4 +4.8
GEM Goldman Sachs ActiveBeta Emerging Markets Equity ETF 1.0 45 34 8.7 +5.1
EEM iShares MSCI Emerging Markets ETF 1.0 68 11 8.3 +4.6
JHEM John Hancock Multifactor Emerging Markets ETF 1.0 55 24 8.8 +5.2
DWCR Arrow DWA Country Rotation ETF 1.0 95 -16 17.6 +13.9
IEMG iShares Core MSCI Emerging Markets ETF 0.9 14 65 8.7 +5.0
AVEM Avantis Emerging Markets Equity ETF 0.9 33 46 9.5 +5.9
SPEM SPDR Portfolio Emerging Markets ETF 0.8 11 68 8.6 +4.9
QEMM SPDR MSCI Emerging Markets StrategicFactors ETF 0.8 30 49 9.4 +5.7
ARKG ARK Genomic Revolution Multi-Sector ETF 0.7 75 4 0.0 -3.7
ISEM Invesco Strategic Emerging Markets ETF 0.7 35 44 10.3 +6.7
FEM First Trust Emerging Markets AlphaDEX Fund 0.7 80 -1 11.8 +8.1
VIDI Vident International Equity Fund 0.6 59 20 11.3 +7.7
TLTE FlexShares Morningstar Emerging Markets Factor Tilt Index 0.6 59 20 11.1 +7.4
DNL WisdomTree Global ex-US Dividend Growth Fund 0.6 58 21 8.0 +4.3
SDG iShares Sustainable MSCI Global Impact ETF 0.5 49 30 6.1 +2.4
ECOW Pacer Emerging Markets Cash Cows 100 ETF 0.5 70 9 13.0 +9.4
EPP iShares MSCI Pacific ex-Japan ETF 0.5 48 31 6.8 +3.1
PXH Invesco FTSE RAFI Emerging Markets ETF 0.5 50 29 13.7 +10.1
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.4 16 63 7.1 +3.5
FXI iShares China Large-Cap ETF 0.4 74 5 13.5 +9.9
ADRE Invesco BLDRS Emerging Markets 50 ADR Index Fund 0.4 18 61 6.1 +2.4
PEK VanEck Vectors ChinaAMC CSI 300 ETF 0.4 60 19 8.1 +4.5
PWC Invesco Dynamic Market ETF 0.4 59 20 6.9 +3.3
JPEM JPMorgan Diversified Return Emerging Markets Equity ETF 0.4 45 34 9.0 +5.3
VSGX Vanguard ESG International Stock ETF 0.4 17 62 7.4 +3.8
SCIX Global X Scientific Beta Asia ex-Japan ETF 0.3 38 41 6.6 +2.9
EEMV iShares Edge MSCI Min Vol Emerging Markets ETF 0.3 25 54 8.4 +4.8
ACWX iShares MSCI ACWI ex U.S. ETF 0.3 32 47 7.5 +3.9
CWI SPDR MSCI ACWI ex-US ETF 0.3 30 49 7.6 +4.0
DBAW Xtrackers MSCI All World ex US Hedged Equity ETF 0.3 40 39 7.4 +3.8
IQDG WisdomTree International Quality Dividend Growth Fund 0.3 38 41 6.4 +2.8
IXUS ishares Core MSCI Total International Stock ETF 0.3 9 70 7.6 +3.9
IHDG WisdomTree International Hedged Quality Dividend Growth Fund 0.3 58 21 6.4 +2.7
MFEM PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF 0.3 49 30 9.0 +5.4
DIM WisdomTree International MidCap Dividend Fund 0.2 58 21 7.6 +4.0
VXUS Vanguard Total International Stock Index Fund 0.2 8 71 7.7 +4.1

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2015 2016 2017 2018 2019 2020E 2021E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2019 2020E 2021E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:
Loncar China BioPharma ETF
Relative
to:
S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

AVOID

Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity 9.6 %
Divided by: Fwd. P/BV 2.2 x
Less: Expense ratio 79 bp
Equals: ALTAR Score 3.7 %
info More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING
1.26 CATEGORY
AVERAGE
1.45
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.